Abstract
Indomethacin (20µg.ml−1), a cyclooxygenase inhibitor, and OKY-1581 (50 ug.ml−1), a thromboxane synthetase inhibitor, did not affect contractions of the superfused human lung parenchymal strips induced by histamine, leukotriene C4 (LTC4) and leukotriene D4 (LTD4). Indomethacin but not OKY-1581 reduced by 50% the myotropic activity of leukotriene A4 (LTA4) on the human lung strips. Injections of LTD4 (100 ng; 0.2 n mole) in the circulation of perfused specimens of human lung did not stimulate the release of prostaglandins (PGs) and thromboxanes (TXs) whereas they produced a large release of these icosanoids from perfused guinea-pig lungs. Perfused human lung specimens almost completely inactivated intraarterial injections of PGE2 (50 ng) and released PGs and TXs upon mechanical stimulation. It is concluded that the actions of leukotrienes C4 and D4 in human lung (parenchymal strips and perfused specimens) are not mediated by the release of PGs and TXs.
Similar content being viewed by others
References
Borgeat P & Sirois P (1981) Leukotrienes. A major step in the understanding of immediate hypersensitivity reaction. Journal of Medicinal Chemistry 24:121–126
Dahlén SE, Hedqvist P, Westlund P, Granström E, Hammarström S, Lindgren JA, Rådmark O (1983) Mechanisms of leukotrienes induced contractions of guinea-pig airways: Leukotriene C4 has a potent direct action whereas leukotriene B4 acts indirectly. Acta Physiologica Scandinavica 118:393–403
Drazen JM, Austen KF, Lewis RA, Clark DA, Goto G, Marfat A, Corey EJ (1980) Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proceedings of the National Academy of Sciences USA 77:4354–4358
Engineer DM, Niederhauser U, Piper PJ, Sirois P (1978) Release of mediators of anaphylaxis: Inhibition of prostaglandin synthesis and the modification or release of Slow-Reacting Substance of Anaphylaxis and Histamine. British Journal of Pharmacology 62:61–66
Folco GC, Hansson G, Granstrom E (1981) Leukotriene C4 stimulates TxA2 formation in isolated sensitized guinea-pig lungs. Biochemical Pharmacology 30:2491–2493
Ford-Hutchinson AW (1981) Leukotriene B4 and neutrophil function: A review. Journal of the Royal Society of Medicine 74:831–833
Hiraku S, Wakitani K, Katsube N, Kawasaki A, Tsuboshima M, Naito J, Ujiie A, Komatsu H, Iisuka K (1972). Pharmacological studies on OKY-1581, a selective thromboxane synthetase inhibitor. Proceedings of the “Vth International Conference on Prostaglandins”, p. 373
Marom Z, Shelhamer JH, Bach MK, Morton DR, Kaliner M (1982) Slow-reacting Substances, Leukotrienes C4 and D4 increase the release of mucus from human airway in vitro. American Review of Respiratory Diseases 126:449–451
Nandiwada P, Hyman AL, Spannake EW, Kadowitz PJ (1982) Pulmonary vascular responses to thromboxane A2 as unmasked by OKY-1581, a novel inhibitor of thromboxane synthesis. Proceedings of the “Vth International Conference on Prostaglandins”, p. 349
Piper RJ, Samhoun MN (1981) The mechanism of action of leukotrienes C4 and D4 in guineapig isolated perfused lung and parenchymal strips of guinea-pig, rabbit and rat. Prostaglandins 21:793–803
Piper RJ, Vane JR (1969) Release of additional factors in anaphylaxis and its antagonism by antiinflammatory drugs. Nature (London) 223:29–35
Sirois P, Borgeat P (1980) From slow reacting substance of anaphylaxis (SRS-A) to leukotriene D4 (LTD4). International Journal of Immunopharmacology 2:281–293
Sirois P, Boreat P, Chagnon M (1984) Role of cyclo-oxygenase products in the lung action of leukotrienes A4, B4, C4, D4 and E4: Use of cyclooxygenase and thromboxane synthetase inhibitors in organ baths and cascade superfusion. Submitted.
Sirois P, Borgeat P, Jeanson A, Roy S, Girard G (1980) The action of leukotriene B4 (LTB4) on the lung. Prostaglandins and Medicine 5:429–444
Sirois P, Brousseau Y (1983) Leukotriene transformation by guinea-pig lungs. Prostaglandins, Leukotrienes and Medicine 10:133–143
Sirois P, Brousseau Y, Borteat P (1983) Leukotriene A4 metabolism is an absolute requirement for its biological activity. Proceedings of the “Vth International Congress of Immunology”, p. 141
Sirois P, Roy S, Borgeat P (1981) The lung parenchymal strip as a sensitive assay for leukotriene B4. Prostaglandins and Medicine 6:153–159
Sirois P, Roy S, Borgeat P (1982) Characterization of leukotrienes receptors on guinea-pig lung parenchyma. International Journal of Immunopharmacology 4:293
Sirois P, Roy S, Borgeat P, Picard S, Vallerand P (1982) Evidence for a mediator role of thromboxane A2 in the myotropic action of leukotriene B4 (LTB4) on the guinea-pig lung. Prostaglandins, Leukotrienes and Medicine 8:157–170
Sirois P, Roy S, Tétreault JP, Borgeat P, Picard S, Corey EJ (1981) Pharmacological activity of leukotrienes A4, B4, C4 and D4 on selected guinea-pig, rat, rabbit and human smooth muscles. Prostaglandins and Medicine 7:327–340
Smith AP (1975) Effect of indomethacin in asthma: Evidence against a role for prostaglandins in its pathogenesis. British Journal of Clinical Pharmacology 2:307–309
Smith JB, Jubiz W (1981) OKY-1581: A selective inhibitor of thromboxane synthesis in vivo and in vitro. Prostaglandins 22:353–363
Wanner A: Personal communication.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chagnon, M., Gentile, J., Gladu, M. et al. The mechanism of action of leukotrienes A4, C4 and D4 on human lung parenchymain vitro . Lung 163, 55–62 (1985). https://doi.org/10.1007/BF02713805
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02713805